Shinagare, Atul B;
Burk, Kristine S;
Kilcoyne, Aoife;
Akin, Esma A;
Chuang, Linus;
Hindman, Nicole M;
Huang, Chenchan;
Rauch, Gaiane M;
Small Jr, William;
Stein, Erica B;
Venkatesan, Aradhana M;
Kang, Stella K.
Cervical cancer is a common gynecological malignancy worldwide. Cervical cancer is staged based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, which was revised in 2018 to incorporate radiologic and pathologic data. Imaging plays an important role in pretreatme...
Lugli, A;
Kirsch, R;
Ajioka, Y;
Bosman, F;
Cathomas, G;
Dawson, H;
El Zimaity, H;
Fléjou, J. F;
Hansen, T. P;
Hartmann, A;
Kakar, S;
Langner, C;
Nagtegaal, I;
Puppa, G;
Riddell, R;
Ristimäki, A;
Sheahan, K;
Smyrk, T;
Sugihara, K;
Terris, B;
Ueno, H;
Vieth, M;
Zlobec, I;
Quirke, P.
Tumor budding is a well-established independent prognostic factor in colorectal cancer but a standardized method for its assessment has been lacking. The primary aim of the International Tumor Budding Consensus Conference (ITBCC) was to reach agreement on an international, evidence-based standardized sco...
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Anticuerpos Monoclonales,
Anticuerpos,
Anticuerpos Monoclonales de Origen Murino/uso terapéutico,
Antineoplásicos,
Esquema de Medicación,
Trasplante de Células Madre Hematopoyéticas,
Linfoma Folicular/patología,
Linfoma/terapia,
Estadificación de Neoplasias,
Rituximab,
Factores de Tiempo
